V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10007811 | 10003595 | 1.73 | 83.3 | Palliative (P) | 2016-01-03 | 2016-01-18 | CAPECITABINE + OXALIPLATIN | 2 | N | 10246831 | CAPECITABINE + OXALIPLATIN |
| 10007812 | 10003596 | 1.8 | 84 | Disease modification (D) | 2017-07-04 | 2017-07-09 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 10247058 | RITUXIMAB |
| 10007813 | 10008322 | 1.63 | null | Neo-adjuvant (N) | 2017-08-02 | 2017-08-05 | Trastuzumab Subcutaneous | 2 | N | 10248439 | TRASTUZUMAB |
| 10007814 | 10003599 | 1.62 | 51.2 | Palliative (P) | 2017-04-03 | 2017-04-15 | FLUOROURACIL + IRINOTECAN | 02 | N | 10249404 | IRINOTECAN + MDG |
| 10007815 | 10003601 | 1.55 | 72 | Disease modification (D) | 2018-03-19 | 2019-03-24 | Paclitaxel 7 day | 2 | N | 10250094 | PACLITAXEL |
| 10007816 | 10003603 | 1.82 | 101.6 | Not known (9) | 2016-05-10 | 2016-05-17 | CAPECITABINE + OXALIPLATIN | 02 | N | 10250247 | CAPECITABINE + OXALIPLATIN |
| 10007817 | 10003608 | 1.7 | 110 | Curative (C) | 2018-06-28 | 2018-08-09 | PEMBROLIZUMAB | N | N | 10253767 | PEMBROLIZUMAB |
| 10007818 | 10003610 | 1.65 | 78.7 | Palliative (P) | 2016-04-26 | 2016-04-26 | Docetaxel | N | N | 10254770 | DOCETAXEL |
| 10007819 | 10003610 | 1.68 | 99 | Curative (C) | 2018-10-02 | 2018-10-30 | CAPECITABINE + OXALIPLATIN | 02 | N | 10254770 | CAPECITABINE + OXALIPLATIN |
| 10007820 | 10003612 | 1.68 | 86 | Curative (C) | 2018-04-04 | 2018-04-22 | Trastuzumab Subcutaneous | N | N | 10256899 | TRASTUZUMAB |
| 10007821 | 10003613 | 1.77 | null | Curative (C) | null | 2017-01-25 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 10258829 | PACLITAXEL |
| 10007822 | 10003614 | 1.68 | 88.1 | Adjuvant (A) | 2014-07-11 | 2014-07-11 | Rituximab | N | N | 10258960 | RITUXIMAB |
| 10007823 | 10003616 | 1.68 | 52.7 | Palliative (P) | 2017-11-26 | 2017-12-13 | Paclitaxel 7 day | N | N | 10260997 | PACLITAXEL |
| 10007824 | 10003619 | 1.68 | 101.5 | null | 2019-01-02 | 2019-01-18 | Irinotecan + Modified De Gramont | 2 | N | 10261233 | IRINOTECAN + MDG |
| 10007825 | 10003622 | 1.74 | 93 | Adjuvant (A) | 2017-11-15 | 2017-11-26 | CHOP R | N | N | 10262656 | CHOP R |
| 10007826 | 10006959 | 1.65 | 72.7 | Adjuvant (A) | 2017-02-15 | 2017-02-15 | PEMBROLIZUMAB | N | N | 10266032 | PEMBROLIZUMAB |
| 10007827 | 10003625 | 1.8 | 95.2 | Disease modification (D) | 2017-10-16 | 2017-10-23 | Docetaxel 75mg/m2 (21 day) | N | N | 10267225 | DOCETAXEL |
| 10007828 | 10003627 | 1.78 | 58.2 | Adjuvant (A) | 2017-09-05 | 2017-09-06 | Capecitabine + Oxaliplatin 21day | N | Y | 10267419 | CAPECITABINE + OXALIPLATIN |
| 10007829 | 10003629 | 1.76 | 142 | Adjuvant (A) | 2017-07-04 | 2017-07-06 | Rituximab | 02 | N | 10268081 | RITUXIMAB |
| 10007830 | 10006965 | 1.77 | 93.3 | Palliative (P) | 2017-06-23 | 2017-06-24 | PEMBROLIZUMAB | N | N | 10275183 | PEMBROLIZUMAB |
| 10007831 | 10003636 | 1.63 | 79 | Palliative (P) | 2018-12-12 | 2018-12-12 | FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 10276088 | OXALIPLATIN + MDG |
| 10007832 | 10003639 | 1.73 | 80.3 | Palliative (P) | 2018-10-11 | 2018-11-06 | PEMBROLIZUMAB | 02 | N | 10276501 | PEMBROLIZUMAB |
| 10007833 | 10003640 | 1.82 | 59 | Palliative (P) | 2015-05-23 | 2015-05-24 | CAPECITABINE + OXALIPLATIN | N | Y | 10276519 | CAPECITABINE + OXALIPLATIN |
| 10007834 | 10003640 | 1.68 | 71.2 | Curative (C) | 2018-07-10 | 2018-07-15 | Rituximab | 02 | null | 10276519 | RITUXIMAB |
| 10007835 | 10003643 | null | 74.9 | Neo-adjuvant (N) | 2016-04-13 | 2016-04-13 | Docetaxel | N | N | 10276753 | DOCETAXEL |
| 10007836 | 10003645 | 1.71 | 50.9 | Palliative (P) | 2017-11-12 | 2018-06-29 | Trastuzumab 21 day maintenance | 02 | N | 10277029 | TRASTUZUMAB |
| 10007837 | 10003647 | 1.66 | 50 | Curative (C) | 2017-07-16 | 2017-07-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | 10277666 | DOCETAXEL |
| 10007838 | 10006973 | 1.69 | 62.7 | Palliative (P) | 2019-02-15 | 2019-02-16 | TRASTUZUMAB | 2 | N | 10277795 | TRASTUZUMAB |
| 10007839 | 10006975 | 1.79 | 65.6 | Palliative (P) | 2016-09-08 | 2016-09-13 | Capecitabine + Oxaliplatin 21day | N | N | 10279100 | CAPECITABINE + OXALIPLATIN |
| 10007840 | 10003657 | 1.82 | null | Palliative (P) | 2019-01-20 | 2019-01-20 | Trastuzumab Subcutaneous | 2 | N | 10279108 | TRASTUZUMAB |
| 10007841 | 10003662 | 1.55 | 57 | Adjuvant (A) | 2019-03-01 | 2019-03-10 | Rituximab | 2 | N | 10279595 | RITUXIMAB |
| 10007842 | 10003666 | 1.67 | 67 | Palliative (P) | 2018-05-06 | 2018-08-27 | Rituximab | N | N | 10279818 | RITUXIMAB |
| 10007843 | 10003672 | 1.65 | 78 | Adjuvant (A) | 2016-12-16 | 2017-01-13 | PEMBROLIZUMAB | 02 | N | 10280855 | PEMBROLIZUMAB |
| 10007844 | 10003674 | 1.77 | 71 | Palliative (P) | 2019-04-17 | 2019-04-20 | Trastuzumab 21 day maintenance | N | N | 10280938 | TRASTUZUMAB |
| 10007845 | 10003676 | 1.7 | 78.7 | Palliative (P) | 2016-04-15 | 2016-04-18 | Rituximab | N | N | 10281194 | RITUXIMAB |
| 10007846 | 10003678 | 1.65 | 57 | Palliative (P) | 2016-02-21 | 2016-03-03 | PEMBROLIZUMAB | N | N | 10281315 | PEMBROLIZUMAB |
| 10007847 | 10003680 | null | 101.5 | Adjuvant (A) | 2017-09-30 | 2017-09-30 | Capecitabine + Oxaliplatin 14day | 02 | null | 10282049 | CAPECITABINE + OXALIPLATIN |
| 10007848 | 10003681 | 1.57 | 66 | Palliative (P) | 2016-08-29 | 2016-09-19 | TRASTUZUMAB | N | N | 10282124 | TRASTUZUMAB |
| 10007849 | 10006985 | 1.86 | 73.6 | Curative (C) | null | 2018-03-31 | TRASTUZUMAB | N | N | 10282350 | TRASTUZUMAB |
| 10007850 | 10006986 | 1.8 | null | Disease modification (D) | 2016-05-20 | 2017-11-16 | Docetaxel | 02 | N | 10282675 | DOCETAXEL |
| 10007851 | 10003683 | 1.64 | 71 | Neo-adjuvant (N) | 2018-01-20 | 2018-01-22 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10282779 | RITUXIMAB |
| 10007852 | 10003685 | 1.76 | 94 | Palliative (P) | null | 2018-01-21 | Trastuzumab Subcutaneous | N | N | 10282824 | TRASTUZUMAB |
| 10007853 | 10003686 | 1.72 | 80 | Palliative (P) | 2017-10-15 | 2017-10-27 | FLUOROURACIL + IRINOTECAN | N | N | 10282832 | IRINOTECAN + MDG |
| 10007854 | 10003688 | 1.88 | 91 | Palliative (P) | 2017-04-21 | 2017-12-16 | TRASTUZUMAB | N | N | 10282967 | TRASTUZUMAB |
| 10007855 | 10003689 | 1.93 | 82.5 | Palliative (P) | 2018-07-12 | 2018-09-20 | Rituximab | N | N | 10283404 | RITUXIMAB |
| 10007856 | 10003691 | 1.7 | null | Adjuvant (A) | 2014-05-21 | 2014-10-05 | Rituximab (Maintenance) | 02 | N | 10283619 | RITUXIMAB |
| 10007857 | 10003695 | 1.85 | 67.7 | Curative (C) | 2015-06-12 | 2017-03-19 | Irinotecan + Modified De Gramont | N | Y | 10283675 | IRINOTECAN + MDG |
| 10007858 | 10003695 | 1.65 | 77 | Palliative (P) | 2016-07-20 | 2017-04-12 | Oxaliplatin + Modified de Gramont | N | N | 10283675 | OXALIPLATIN + MDG |
| 10007859 | 10003697 | 1.7 | 63 | Palliative (P) | 2017-03-01 | 2017-03-03 | CAPECITABINE + OXALIPLATIN | null | null | 10284056 | CAPECITABINE + OXALIPLATIN |
| 10007860 | 10006991 | null | 67 | Adjuvant (A) | 2017-12-14 | 2017-12-15 | CHOP R - 21 days | 02 | N | 10284374 | CHOP R |